Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Crystal form of butyric acid clevidipine

A kind of technology of clevidipine butyrate and crystal form, applied in the field of medicine, can solve problems such as research report of clevidipine butyrate crystal form

Inactive Publication Date: 2010-07-07
WUHAN WUYAO SCI & TECH
View PDF2 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But so far there is no report on the crystal form of clevidipine butyrate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystal form of butyric acid clevidipine
  • Crystal form of butyric acid clevidipine
  • Crystal form of butyric acid clevidipine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0103] The preparation of clevidipine butyrate I crystal form:

[0104] To 10 g of clevidipine butyrate solid, add 40 ml of isopropanol, heat to dissolve, add 0.5 g of activated carbon for decolorization, and filter while hot to obtain a filtrate. Add 60ml of water to the filtrate, keep the temperature at 20-25°C, stir for 6h, a white solid is precipitated, filtered, and dried to obtain crystal form I of clevidipine butyrate.

Embodiment 2

[0106] The preparation of clevidipine butyrate I crystal form:

[0107] To 10 g of clevidipine butyrate solid, add 45 ml of isopropanol, heat to dissolve, add 0.5 g of activated carbon for decolorization, and filter while hot to obtain a filtrate. Add 70ml of water to the filtrate, keep the temperature at 25-30°C, stir for 12h, a white solid is precipitated, filtered, and dried to obtain crystals of clevidipine butyrate in I crystal form.

Embodiment 3

[0109] The preparation of clevidipine butyrate I crystal form:

[0110] 10kg of clevidipine butyrate solid, add 32kg of isopropanol, heat to dissolve, add 500g of activated carbon for decolorization, filter while it is hot, add 60kg of water to the filtrate, add a small amount of clevidipine butyrate crystal seed of I crystal form, keep the temperature at 21- After stirring for 9 hours at 25°C, a white solid was precipitated, centrifuged, and dried to obtain Form I crystals of clevidipine butyrate.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
crystallization temperatureaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of medicines, relating to a chemical drug and a preparation method thereof, in particular to a crystal form of butyric acid clevidipine and a preparation method thereof. The position of powder X-ray diffraction pattern peak of the crystal is at 7.5 degrees, 8.5degrees, 10.1 degrees, 16.3 degrees, 20.3 degrees, and 24.8 Ddegrees+ / -0.2degrees 2 theta, the absorption peak of a differential scanning calorimetry pattern is at 140.5 DEG C, and the position of the characteristic peak of an infrared pattern is at 3332, 1732 and 1707 cm<1>. The crystal form of butyric acid clevidipine is prepared by adding a solvent which can dissolve the solid to the butyric acid clevidipine, heating and dissolving, then adding activated carbon for decoloration, filtering during heating, cooling the filtered liquid so as to crystallize butyric acid clevidipine crystal, and then filtering and drying. The physical and chemical properties of the invention are stable, and the invention is convenient for being made to stable pharmaceutical preparations in large scale.

Description

Technical field: [0001] The invention belongs to the technical field of medicine, and in particular relates to a chemical drug and a preparation method thereof, in particular to a crystal form of clevidipine butyrate and a preparation method thereof. Background technique: [0002] Clevidipine butyrate, the chemical name is 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate Base (1-oxobutoxy) methyl ester is a short-acting dihydropyridine calcium channel blocker, and its chemical structure is as follows: [0003] [0004] The U.S. FDA approved The Medicines Company's clevidipine butyrate emulsion for intravenous injection (trade name Cleviprex) in August 2008, for the treatment of hypertensive patients who are not suitable for oral medication or oral medication is ineffective, and can also be used for the treatment of surgical Acute elevation of blood pressure after surgery. Clevidipine butyrate can selectively inhibit the influx of calcium ions ou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D211/90
Inventor 杨波孙华君黄璐耿海明杨尚金穆惠芳朱毅马芳岚沈婕
Owner WUHAN WUYAO SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com